HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Widefield Swept-Source Optical Coherence Tomography Angiography Findings in Wagner Syndrome.

AbstractPURPOSE:
To describe novel clinical and angiographic findings in Wagner syndrome.
METHODS:
A retrospective case series of three related patients with Wagner syndrome. Patients underwent standard OCT, B-scan ultrasonography, and fluorescein angiography in addition to wide field swept-source OCT angiography (WF SS-OCTA) (PLEX® Elite 9000, Carl Zeiss Meditec Inc.). Patients underwent genetic testing for a panel of hereditary vitreoretinopathies.
RESULTS:
Three related patients with Wagner syndrome were identified. All were found to have prominent vitreous strands, abnormal vitreoretinal adhesions, peripheral retinal holes, and varying degrees of myopia. A mid-peripheral tractional ridge was identified in all 6 eyes. All patients were positive for a known pathologic intron variant in the VCAN gene (4004-5T-A). WF SS-OCTA (12 mm x 12 mm) was performed in two patients and demonstrated perivascular capillary loss in the superficial capillary plexus along the arcades bilaterally. One patient demonstrated associated retinal atrophy within the area of capillary loss. The capillary loss extended beyond the margin of retinal atrophy.
CONCLUSION:
The unusual finding of a mid-peripheral tractional ridge of the retina associated with myopia led to a genetic diagnosis of Wagner Syndrome. WF SS-OCTA demonstrated a novel feature of perivascular loss of the superficial retinal capillary plexus. This result suggests that vitreous traction may cause localized microvasculature dysfunction and subsequent retinal atrophy in Wagner syndrome. This is the first known evaluation of Wagner syndrome utilizing OCTA.
AuthorsIsaac D Bleicher, Itika Garg, Sandra Hoyek, Emily Place, John B Miller, Nimesh A Patel
JournalRetinal cases & brief reports (Retin Cases Brief Rep) (Aug 11 2022) ISSN: 1937-1578 [Electronic] United States
PMID36007184 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: